
### [NCIT:C3714](http://purl.obolibrary.org/obo/NCIT_C3714)
**Label:** Epithelioid Sarcoma

**Subclasses:** [NCIT:C9409](http://purl.obolibrary.org/obo/NCIT_C9409) (Epithelioid Sarcoma NCI Grade 2), [NCIT:C8095](http://purl.obolibrary.org/obo/NCIT_C8095) (Childhood Epithelioid Sarcoma), [NCIT:C5059](http://purl.obolibrary.org/obo/NCIT_C5059) (Recurrent Epithelioid Sarcoma), [NCIT:C7944](http://purl.obolibrary.org/obo/NCIT_C7944) (Adult Epithelioid Sarcoma), [NCIT:C8799](http://purl.obolibrary.org/obo/NCIT_C8799) (Metastatic Epithelioid Sarcoma), [NCIT:C8800](http://purl.obolibrary.org/obo/NCIT_C8800) (Primary Epithelioid Sarcoma), [NCIT:C9410](http://purl.obolibrary.org/obo/NCIT_C9410) (Epithelioid Sarcoma NCI Grade 3), 

**Class expressions from DL-Learner:**

- [NCIT:C45809](http://purl.obolibrary.org/obo/NCIT_C45809) (Gain of Chromosome 11q13) 57.14%
- [NCIT:C41435](http://purl.obolibrary.org/obo/NCIT_C41435) (Malignant Epithelioid Cell) 57.14%
- [NCIT:C36564](http://purl.obolibrary.org/obo/NCIT_C36564) (i(8)(q10)) 57.14%
- [NCIT:C36506](http://purl.obolibrary.org/obo/NCIT_C36506) (Loss of Chromosome 22q) 57.14%
- [NCIT:C36503](http://purl.obolibrary.org/obo/NCIT_C36503) (Loss of Chromosome 8p) 57.14%
- [NCIT:C36104](http://purl.obolibrary.org/obo/NCIT_C36104) (Aggressive Clinical Course) 57.14%
- Thing 51.72%
- [NCIT:C2950](http://purl.obolibrary.org/obo/NCIT_C2950) (Cytogenetic Abnormality) 34.33%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 33.00%
- [NCIT:C3897](http://purl.obolibrary.org/obo/NCIT_C3897) (Isochromosome) 29.50%
- [NCIT:C37104](http://purl.obolibrary.org/obo/NCIT_C37104) (Neoplastic Epithelioid Cell) 29.50%
- [NCIT:C6825](http://purl.obolibrary.org/obo/NCIT_C6825) (Numerical Chromosomal Abnormality) 28.65%
- [NCIT:C36315](http://purl.obolibrary.org/obo/NCIT_C36315) (Chromosomal Loss) 24.39%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 16.20%
- [NCIT:C36438](http://purl.obolibrary.org/obo/NCIT_C36438) (Chromosomal Gain) 13.82%


